Panel Discussion: Defining a ‘Super-Donor’ & Discussing Cell Source Considerations to Maximize Off-the-Shelf Product Quality

Time: 12:00 pm
day: Day 2 am track a


  • Identifying and characterizing the most robust sources and donors
  • Questioning what constitutes a ‘super-donor’: the percentage of gamma delta T cells in circulation, or other markers at play
  • Managing donor selection, variation, and evolving process development for each donor
  • Developing a master cell bank for scalable, consistent, offthe- shelf products